Strategic Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Hold |
3,480
| – | – | 0.05% | 153 |
|
|
2025
Q1 | $256K | Sell |
3,480
-148
| -4% | -$10.9K | 0.05% | 166 |
|
|
2024
Q4 | $238K | Buy |
3,628
+104
| +3% | +$6.81K | 0.04% | 178 |
|
|
2024
Q3 | $275K | Hold |
3,524
| – | – | 0.05% | 181 |
|
|
2024
Q2 | $275K | Sell |
3,524
-1,050
| -23% | -$81.9K | 0.05% | 178 |
|
|
2024
Q1 | $310K | Buy |
4,574
+58
| +1% | +$3.93K | 0.06% | 171 |
|
|
2023
Q4 | $304K | Buy |
4,516
+16
| +0.4% | +$1.08K | 0.06% | 169 |
|
|
2023
Q3 | $305K | Hold |
4,500
| – | – | 0.06% | 164 |
|
|
2023
Q2 | $322K | Hold |
4,500
| – | – | 0.06% | 154 |
|
|
2023
Q1 | $312K | Hold |
4,500
| – | – | 0.06% | 161 |
|
|
2022
Q4 | $305K | Hold |
4,500
| – | – | 0.07% | 154 |
|
|
2022
Q3 | $246K | Hold |
4,500
| – | – | 0.05% | 164 |
|
|
2022
Q2 | $297K | Hold |
4,500
| – | – | 0.06% | 153 |
|
|
2022
Q1 | $298K | Buy |
+4,500
| New | +$298K | 0.05% | 161 |
|